Answers are grounded in this paper and cite their sources.
Phase angle (PhA) is a bioelectrical parameter associated with body cell mass, fluid distribution, frailty, and adverse clinical outcomes. Because PhA varies with age and sex, absolute values are difficult to interpret. Whether deviation from age- and sex-expected PhA reflects multidomain clinical burden across adulthood is unknown. We investigated whether phase angle deviation (ΔPhA), defined as observed PhA minus age- and sex-expected PhA, is associated with the presence and accumulation of clinically confirmed diagnoses across five major clinical domains in adults 18 to 90 years. Outcomes were the presence of at least one clinically confirmed diagnosis in the cardiovascular, malignant, psychological, chronic inflammatory, or metabolic-syndrome domain and the number of domains present. Modified Poisson regression estimated adjusted Prevalence Ratios (PRs), and multivariable linear regression quantified the burden gradient. The analysis included 94,552 adults (60,803 women [64.3%]; mean [SD] age, 46.44 [15.10] years), including 51,955 controls and 42,597 participants with at least one clinical domain. Each 1° lower ΔPhA was associated with a 13.3% higher adjusted prevalence of at least one domain (PR, 1.133; 95% CI, 1.123–1.144; p < .001). Compared with controls, adjusted ΔPhA was − 0.154° with one domain, -0.209° with two, -0.317° with three, and − 0.391° with four or more domains. In conclusion, PhA values below those expected for age and sex were associated with progressively greater multidomain disease burden.
No takes yet. Share an insight, caveat, or question.
Boschiero et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: